$CNC

Burdick Kenneth A sold $5.2M of CNC

Burdick Kenneth A sold 80,000 shares of CENTENE CORP (CNC) at $64.55 ($5.16M total) on 2026-06-10.

Original reporting
SEC EDGAR · Burdick Kenneth A
Published Jun 11, 2026, 9:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNC
Bearish
medium confidence
Mentioned
$CNC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNCBearishLow
01

Why it matters

The only new information is the disclosed sale size, price, and post-transaction holdings; it may slightly affect sentiment but lacks fundamental triggers.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a sustained repricing.

03

What to watch

No 10b5-1 plan is stated, but the filing alone cannot distinguish discretionary selling from scheduled personal liquidity needs; traders should check for repeated insider activity around the same period.

Relevance 6/10Novelty 6/10Timing: New SEC Form 4 filed June 11; sale executed June 10

Background

The article is an SEC Form 4 insider transaction disclosure for Centene’s director Kenneth A. Burdick.

Company-level read

Ticker impact

$CNCBearishMedium confidence
Context

Centene director Kenneth A. Burdick sold 80,000 shares in an open-market transaction worth about $5.164M, per a new SEC Form 4 filing.

Expected impact

Limited near-term impact; any effect is likely sentiment-driven and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is primary-source and time-stamped, but it does not indicate company-specific deterioration (no earnings, guidance, or regulatory action) and notes no 10b5-1 plan.

Market effects

Minimal; single-insider sale does not reset sector fundamentals.

None indicated.

None indicated.

Counterpoint

Director sales can be routine liquidity/portfolio rebalancing and may not reflect forward-looking views, especially without evidence of a broader pattern.

Key entities

  • CENTENE CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • Burdick Kenneth A

    Director who sold 80,000 shares in an open-market sale.

Related articles

$CNCMed

Are Wall Street Analysts Predicting Centene Stock Will Climb or Sink?

Centene (CNC) is the focus. After FY2026 Q2 results on July 28, shares fell 5.1% as membership declined despite revenue rising 9.9% to $53.6B and adjusted diluted EPS reaching $2.51. Centene raised FY2026 revenue guidance to $193.5B-$197.5B and adjusted EPS to over $4.80. Analysts expect 2026 adjusted EPS of $4.89; Bernstein lifted its price target to $79.

$HCAMed

Uninsured patients rise sharply, hospitals report, citing Obamacare cuts | Chattanooga Times Free Press

More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.

$CNCMedAI 8/10

Centene Corporation Q2 2026 Earnings Call Summary

Strategic Performance and Operational Context Management raised full-year 2026 adjusted EPS guidance to greater than $4.80, citing underlying business strength and a more fully informed view of Marketplace risk adjustment positioning. Marketplace results outperformed expectations following a year of disciplined repricing and data analysis that confirmed the relative acuity of the population.